Cargando…
Improvement Efficacy of Influenza Nanovaccine in Combination with Hemokinin-1 Molecular Adjuvant
BACKGROUND: H9N2 avian influenza viruses have the potential to become the next human pandemic threat and next generation vaccine technologies are needed. Current studies introduce nanoparticles as a proper vaccine delivery vehicle for induction of protective immunity. In this study, the efficacy of...
Autores principales: | Dehghan, Atefeh, Shahsavandi, Shahla, Jabalameli, Leila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Avicenna Research Institute
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252024/ https://www.ncbi.nlm.nih.gov/pubmed/30555652 |
Ejemplares similares
-
Self-adjuvanting cancer nanovaccines
por: Liao, Zhiyun, et al.
Publicado: (2022) -
Expression and function of human hemokinin-1 in human and guinea pig airways
por: Grassin-Delyle, Stanislas, et al.
Publicado: (2010) -
Hemokinin-1 is a mediator of chronic restraint stress-induced pain
por: Borbély, Éva, et al.
Publicado: (2023) -
A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer
por: Ni, Qianqian, et al.
Publicado: (2020) -
Anti-Tumor Efficacy of an Adjuvant Built-In Nanovaccine Based on Ubiquitinated Proteins from Tumor Cells
por: Huang, Fang, et al.
Publicado: (2020)